Mydecine Innovations Group Inc.
MYCO
CNSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 200.00 | 6.80K | 200.00 | 44.50K | 9.90K |
| Total Receivables | -- | -- | 34.90K | 87.40K | 105.90K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 200.00 | 6.80K | 35.20K | 132.00K | 115.80K |
|
|
|||||
| Total Current Assets | 200.00 | 6.80K | 35.20K | 132.00K | 115.80K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 200.00 | 6.80K | 35.20K | 132.00K | 115.80K |
|
|
|||||
| Total Accounts Payable | 1.69M | 1.59M | 1.82M | 5.26M | 4.29M |
| Total Accrued Expenses | 4.39M | 4.12M | 3.79M | 2.95M | 2.63M |
| Short-term Debt | 89.00K | 170.40K | 166.90K | 168.50K | 163.90K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.06M | 4.71M | 4.61M | 4.66M | 4.33M |
| Total Finance Division Other Current Liabilities | -- | -- | 25.80K | -- | -- |
| Total Other Current Liabilities | -- | -- | 25.80K | -- | -- |
| Total Current Liabilities | 11.23M | 10.60M | 10.41M | 13.05M | 11.41M |
|
|
|||||
| Total Current Liabilities | 11.23M | 10.60M | 10.41M | 13.05M | 11.41M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 89.00K | 170.40K | 166.90K | 168.50K | 163.90K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 11.23M | 10.60M | 10.41M | 13.05M | 11.41M |
|
|
|||||
| Common Stock & APIC | 104.89M | 99.53M | 99.43M | 105.89M | 104.52M |
| Retained Earnings | -116.33M | -110.32M | -109.99M | -119.02M | -116.02M |
| Treasury Stock & Other | 209.50K | 198.80K | 198.60K | 211.50K | 208.80K |
| Total Common Equity | -11.23M | -10.59M | -10.37M | -12.91M | -11.29M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -11.23M | -10.59M | -10.37M | -12.91M | -11.29M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -11.23M | -10.59M | -10.37M | -12.91M | -11.29M |
|
|
|||||